Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza Timing in Cataract Surgery Combined with MIGS
NCT04465864Phase 4Completed
- Sponsor
- Wolstan and Goldberg Eye Associates
- Start
- Feb 2020
- Primary completion
- Dec 2020
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in ocular inflammation, sponsored by Wolstan and Goldberg Eye Associates. Started Feb 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04465864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465864.